02 April 2015 | Regulatory | By BioSpectrum Bureau
Parexel launches enhanced platform for regulatory management
The platform provides business intelligence, simplified usability, compliance and interoperability
Singapore: Global biopharmaceutical service provider, Parexel International, has launched Regulatory Information Management (RIM) platform: LIQUENT InSight 6.0 to supports the entire regulatory product lifecycle, from early planning of registration targets through product retirement, with robust submission planning, publishing, viewing and registration management capabilities.
Parexel mentions that while biopharmaceutical companies and the patients who can benefit from new drugs are located throughout the world, there is no single international regulatory body to review and approve new medicine applications. For new and innovative medicines to successfully reach patients and maintain regulatory compliance throughout the product lifecycle, biopharmaceutical companies must navigate the complex, global regulatory and region-specific regulations.
"LIQUENT InSight 6.0 simplifies navigation of the global regulatory environment and provides the submission and registration management tools needed to more quickly bring treatments to market and effectively maintain them throughout their lifespan," said Mr Xavier Flinois, president, PAREXEL Informatics. "As an essential part of the drug development journey, the LIQUENT InSight platform centralizes a company's regulatory information to drive standardization, improve collaboration, and helps to ensure compliance, eliminate waste, reduce costs, and increase efficiencies so more patients can quickly and safely receive the treatments they need."
Enhancements to the LIQUENT InSight platform include business intelligence, simplified usability, compliance and interoperability.